Botanix Pharmaceuticals Limited (ASX:BOT)
0.1250
+0.0150 (13.64%)
Sep 12, 2025, 4:10 PM AEST
Botanix Pharmaceuticals Market Cap
Botanix Pharmaceuticals has a market cap or net worth of 245.17 million as of September 12, 2025. Its market cap has decreased by -61.30% in one year.
Market Cap
245.17M
Enterprise Value
181.42M
Revenue
5.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.13
Market Cap Chart
Since July 15, 2016, Botanix Pharmaceuticals's market cap has increased from 12.26M to 245.17M, an increase of 1,899.00%. That is a compound annual growth rate of 38.66%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 11, 2025 | 215.75M | -72.71% |
Dec 31, 2024 | 790.67M | 168.97% |
Dec 29, 2023 | 293.96M | 367.07% |
Dec 30, 2022 | 62.94M | 15.49% |
Dec 31, 2021 | 54.50M | -55.20% |
Dec 31, 2020 | 121.64M | 52.51% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Jul 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 99.70B |
Pro Medicus | 31.22B |
Cochlear | 19.46B |
Sonic Healthcare | 11.10B |
Ramsay Health Care | 7.67B |
Ansell | 4.83B |
Telix Pharmaceuticals | 4.66B |
Mesoblast | 2.97B |